Application of an In Vitro Infection Model and Simulation for Reevaluation of Fluoroquinolone Breakpoints for Salmonella enterica Serotype Typhi

Salmonella enterica serotype Typhi and nontyphoidal Salmonella remain major causes of morbidity and mortality worldwide. Ampicillin, trimethoprim-sulfamethoxazole, and chloramphenicol no longer provide reliable coverage of Salmonella, and fluoroquinoloes have emerged as first-line treatment options....

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Booker, Brent M., Smith, Patrick F., Forrest, Alan, Bullock, Julie, Kelchlin, Pamela, Bhavnani, Sujata M., Jones, Ronald N., Ambrose, Paul G.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society for Microbiology 2005
Soggetti:
Experimental Therapeutics
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC1087614/
https://ncbi.nlm.nih.gov/pubmed/15855495
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.49.5.1775-1781.2005
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi